1
![Obalon Therapeutics]()
![Obalon Therapeutics]()
![Obalon Therapeutics]()
Obalon Therapeutics
Leadership team
Steve Pacelli (Founder)
Products/ Services
Health Care, Medical, Therapeutics
Number of Employees
50 - 100
Headquarters
Carlsbad, California, United States
Established
2008
Company Registration
SEC CIK number: 0001427570
Traded as
NASDAQ:OBLN
URL
Overview
Location
Summary
Headquartered in San Diego, Obalon Therapeutics, Inc. is a clinical-stage medical device company focused on developing and commercializing novel balloon-based drug delivery systems to treat obesity.
History
Obalon Therapeutics was founded in 2010 and launched its first product, the Obalon Balloon System, in 2017. The Obalon Balloon System was designed to provide a reversible, non-surgical and non-pharmacological weight loss solution. It is the world’s first and only swallowable balloon-based weight loss system.
Mission
Obalon Therapeutics is dedicated to developing technologies that empower people to lead healthier lives.
Vision
Obalon Therapeutics seeks to become the global leader in the weight loss market, setting the standard for innovation and quality in the medical device industry.
Key Team
Steve Pacelli (Founder)
Recognition and Awards
Obalon Therapeutics has been awarded the American Heart Association’s Start! Innovation Award and was recognized by Frost & Sullivan with the Medical Device Company of the Year award in 2018.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Steve Pacelli (Founder)
Products/ Services
Health Care, Medical, Therapeutics
Number of Employees
50 - 100
Headquarters
Carlsbad, California, United States
Established
2008
Company Registration
SEC CIK number: 0001427570
Traded as
NASDAQ:OBLN
URL